Clark Capital Management Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,089
| Closed | -$291K | – | 346 |
|
2022
Q3 | $291K | Sell |
1,089
-4
| -0.4% | -$1.07K | ﹤0.01% | 315 |
|
2022
Q2 | $223K | Buy |
1,093
+115
| +12% | +$23.5K | ﹤0.01% | 314 |
|
2022
Q1 | $206K | Sell |
978
-322
| -25% | -$67.8K | ﹤0.01% | 357 |
|
2021
Q4 | $312K | Buy |
+1,300
| New | +$312K | ﹤0.01% | 313 |
|
2019
Q2 | – | Sell |
-73,412
| Closed | -$17.4M | – | 293 |
|
2019
Q1 | $17.4M | Sell |
73,412
-4,516
| -6% | -$1.07M | 0.41% | 103 |
|
2018
Q4 | $23.5M | Buy |
+77,928
| New | +$23.5M | 0.63% | 64 |
|
2018
Q2 | – | Sell |
-63,734
| Closed | -$17.5M | – | 269 |
|
2018
Q1 | $17.5M | Buy |
63,734
+5,888
| +10% | +$1.61M | 0.55% | 74 |
|
2017
Q4 | $18.4M | Buy |
+57,846
| New | +$18.4M | 0.56% | 66 |
|
2017
Q3 | – | Sell |
-926
| Closed | -$251K | – | 295 |
|
2017
Q2 | $251K | Sell |
926
-15,804
| -94% | -$4.28M | 0.01% | 245 |
|
2017
Q1 | $4.57M | Sell |
16,730
-17,949
| -52% | -$4.91M | 0.2% | 118 |
|
2016
Q4 | $9.83M | Buy |
34,679
+5,749
| +20% | +$1.63M | 0.51% | 65 |
|
2016
Q3 | $9.06M | Buy |
+28,930
| New | +$9.06M | 0.52% | 57 |
|